alimentary pharmacology & therapeutics | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

alimentary pharmacology & therapeutics

Login or register to claim ownership or editorship of this journal.
Indexings
ncbi ulakbim sci
Short Name aliment pharmacol ther
Abbreviated Name aliment pharmacol ther
ISSN 1365-2036
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (10 total)

2007
Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori
Fischbach L;Evans EL;;
Vol. 26 , No. 3 , pp. -
326 views Abstract
2005
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens
Koivisto TT;Rautelin HI;Voutilainen ME;Heikkinen MT;Koskenpato JP;Färkkilä MA;;
Vol. 21 , No. 6 , pp. -
326 views Abstract
2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease
Feagan BG;Sandborn WJ;Baker JP;Cominelli F;Sutherland LR;Elson CO;Salzberg BA;Archambault A;Bernstein CN;Lichtenstein GR;Heath PK;Cameron S;Hanauer SB;;
Vol. 21 , No. 4 , pp. -
303 views Abstract
2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease
Kiss LS;Szamosi T;Molnar T;Miheller P;Lakatos L;Vincze A;Palatka K;Barta Z;Gasztonyi B;Salamon A;Horvath G;Tóth GT;Farkas K;Banai J;Tulassay Z;Nagy F;Szenes M;Veres G;Lovasz BD;Vegh Z;Golovics PA;Szathmari M;Papp M;Lakatos PL; ;;
Vol. 34 , No. 8 , pp. -
297 views Abstract
2020
Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk
Prizment AE;Staley C;Onyeaghala GC;Vivek S;Thyagarajan B;Straka RJ;Demmer RT;Knights D;Meyer KA;Shaukat A;Sadowsky MJ;Church TR;;
, pp. -
256 views Abstract
2020
Letter: the gluten-free diet as a bottom-up approach for irritable bowel syndrome. Authors' reply.
Tuck, Caroline;Vanner, Stephen;Camilleri, Michael;Jing Wang, Xiao;
Vol. 51 , No. 1 , pp. 185-186
237 views DOI
2005
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial
Kotowska M;Albrecht P;Szajewska H;;
Vol. 21 , No. 5 , pp. -
225 views Abstract
2019
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.
Gawrieh, Samer;Dakhoul, Lara;Miller, Ethan;Scanga, Andrew;deLemos, Andrew;Kettler, Carla;Burney, Heather;Liu, Hao;Abu-Sbeih, Hamzah;Chalasani, Naga;Wattacheril, Julia;
219 views DOI Abstract
2008
Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children
Ruszczyński M;Radzikowski A;Szajewska H;;
Vol. 28 , No. 1 , pp. -
216 views Abstract
2020
Letter: the gluten-free diet as a bottom-up approach for irritable bowel syndrome.
Rej, Anupam;Buckle, Rachel Louise;Shaw, Christian Charles;Trott, Nick;Aziz, Imran;Surendran Sanders, David;
Vol. 51 , No. 1 , pp. 184-185
215 views DOI
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0
Journament